EGFR and non-small cell lung carcinoma: Thematic map analysis has uncovered crucial research directions that have made notable progress within the field, including the investigation of KRAS mutation in lung cancer, the assessment of prognosis for BRAF or RAS mutations, and the clarification of EGFR’s involvement in NSCLC and lung adenocarcinoma.